The report provides a detailed analysis essential for establishing a Ganaxolone production plant. It encompasses all critical aspects necessary for Ganaxolone production, including the cost of Ganaxolone production, Ganaxolone plant cost, Ganaxolone production costs, and the overall Ganaxolone production plant cost. Additionally, the study covers specific expenditures associated with setting up and operating a Ganaxolone production plant. These encompass production processes, raw material requirements, utility requirements, infrastructure needs, machinery and technology requirements, manpower requirements, packaging requirements, transportation requirements, and more.
Ganaxolone is a synthetic neuroactive steroid that finds important applications in the medical and pharmaceutical fields. It is widely used as a drug to help manage seizures linked to CDKL5 deficiency disorder, which is a rare condition that begins in early childhood. It works by modulating GABA_A receptors in the central nervous system to enhance inhibitory neurotransmission, helping to stabilise brain activity. It is used as a therapeutic agent for the treatment of neurological disorders, including certain types of epilepsy and seizure-related conditions. Additionally, it is being explored for use in managing other neurological and mood-related disorders due to its calming effects on overactive neural circuits.
The demand for Ganaxolone is mainly led by its application as a medication to manage seizures and other seizure-related problems, which significantly contributes to market growth. Its application as a treatment for seizures linked to CDKL5 deficiency disorder strongly drives its demand in the pharmaceutical industry. Its usage as an oral and injectable formulation for both clinical treatment and ongoing research in neuropharmacology further contributes to its demand in the medical and pharmaceutical research industries. Its involvement in helping stabilise brain activity in patients who struggle with early-onset, hard-to-control seizures further strengthens its demand in the neurological and pediatric healthcare industries.
Growing research into its potential use for other seizure disorders and certain neurodevelopmental conditions also contributes to its market growth. Along with its medical applications, several factors, including the cost and availability of raw materials, strict adherence to drug-production rules, and maintaining consistent product purity, directly influence industrial Ganaxolone procurement worldwide. In addition, advancements in clinical science, dependable supplier networks, smooth distribution channels, and strong sustainability practices also affect its procurement strategies across pharmaceutical markets globally.
Raw Material for Ganaxolone Production
According to the Ganaxolone production plant project report, the major raw materials for Ganaxolone production include Pregnenolone-Ethylene glycol- Calcium hypochlorite-TEMPO- Methylmagnesium bromide.
Production Process of Ganaxolone
The extensive Ganaxolone production cost report consists of the following industrial production process:
- Production via Chemical Synthesis: The production process of Ganaxolone begins with the natural steroid pregnenolone, where the keto group is first protected by forming an acetal through reaction with boiling ethylene glycol in toluene. Then, the protected intermediate is oxidized to form a ketone, which can be achieved using eagents, such as calcium hypochlorite and TEMPO. Further, a methyl group is introduced by reacting the ketone with methylmagnesium bromide in the presence of lithium chloride and ferric chloride, which produce a tertiary alcohol. Finally, the acetal protecting group is removed by treatment with iodine in a mixture of dichloromethane and acetone, forming Ganaxolone with high overall efficiency, as the final product.
Ganaxolone is a synthetic neuroactive steroid that appears as a white to off-white crystalline solid with no odour. The molecular formula of the compound is C22H36O2, and its molar mass is approximately 332.52 g/mol. The flash point of the compound is about 185 degree Celsius. The density of the solid is about 1.036 g/cm³. It has a melting point in the range of 190–198 degree Celsius, and its boiling point is around 434.8 degree Celsius. It is generally insoluble in water but is soluble in organic solvents such as dimethyl sulfoxide (DMSO). Ganaxolone acts as a positive allosteric modulator of GABA_A receptors, which enhances inhibitory neurotransmission in the central nervous system. The handling of the pure powder should be done with care, using standard protective gear (gloves, lab coat) to minimise inhalation or contact risk.